| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/13/2004 | CN1170594C 弯曲菌疫苗 Campylobacter vaccine |
| 10/13/2004 | CN1170593C Immunogenic compsns to CK-b/gastrin-receptor and methods for treatment of tumors |
| 10/13/2004 | CN1170592C New use of melagatran |
| 10/13/2004 | CN1170591C Pharmaceutical prepn. contg. fibrinolysin activators |
| 10/13/2004 | CN1170590C Health-care product containing growth factor and its preparation method |
| 10/13/2004 | CN1170589C The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 10/13/2004 | CN1170588C Orally applied medicine containing Nostoc which expressing human tumor necrosin factor alpha |
| 10/13/2004 | CN1170587C I (Robinia Pseudoacacia) lectin and its uses |
| 10/13/2004 | CN1170586C Pharmaceutical formulation of Didemnin compound |
| 10/13/2004 | CN1170585C Remedies for nervous diseases |
| 10/13/2004 | CN1170584C Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives |
| 10/13/2004 | CN1170551C Hypoglycemic, antihypertensive and antisenility powder for dietotherapy and its preparing process |
| 10/13/2004 | CN1170550C Alpha-glucosidase inhibitor |
| 10/13/2004 | CN1170543C Use of PEG-IFN-alpha and triazloe nucleoside for treatment of chronic hepatitis C |
| 10/13/2004 | CN1170527C Therapeutic perparation for inhalation containing parathyroid hormone, PTH |
| 10/12/2004 | US6803486 Peptidomimetic; n-aminobutyl-n'-nitroguanidine derivatives |
| 10/12/2004 | US6803481 Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. the pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary |
| 10/12/2004 | US6803466 Effective against drug-resistant mutants |
| 10/12/2004 | US6803454 Method for extraction and purification of cartilage type proteoglycan |
| 10/12/2004 | US6803452 RPTP-β antibodies |
| 10/12/2004 | US6803450 Fusion protein; genetic engineering; energy storage |
| 10/12/2004 | US6803449 Polypeptide for use in the diagnosis and treatment viral diseases |
| 10/12/2004 | US6803448 GBS toxin receptor |
| 10/12/2004 | US6803360 Resistance to said radiation or drug treatment is not a result of overexpression of her-2, comprising introducing into said cell an antisense nucleic acid |
| 10/12/2004 | US6803359 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 10/12/2004 | US6803358 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 10/12/2004 | US6803357 Inhibitors of dipeptidylpeptidase iv (dpiv) sufficient to treat type ii diabetes but not sufficient to suppress the immune system |
| 10/12/2004 | US6803225 Expression vector for use transformation of yeast cells |
| 10/12/2004 | US6803213 Having one or more amino acid substitutions that confer receptor agonist or antagonist properties |
| 10/12/2004 | US6803212 Low oxygen affinity mutant hemoglobins |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 10/12/2004 | US6803192 B7-H1, a novel immunoregulatory molecule |
| 10/12/2004 | US6803059 Anti-tumor metallocomplexes of crude extracts from Canavalia ensiformis |
| 10/12/2004 | US6803046 Containing stabilizer, solubilizer, chelator, bulking agent, tonicity adjuster and buffer; fewer degradants; consistent potency |
| 10/12/2004 | US6803044 Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus |
| 10/12/2004 | US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM |
| 10/12/2004 | US6803038 Stimulating plasmin production; inhibiting fibrin production and adhesion of human thrombocytes on endothelilum cells |
| 10/12/2004 | US6803035 Administering an egg product to the animal suffering from the diarrhea, and the egg product is obtained from a hyperimmunized avian with an immunogenic or genetic vaccine |
| 10/12/2004 | CA2238993C Methods for treating prostate cancer with lhrh antagonists |
| 10/12/2004 | CA2110585C Therapeutic fragments of von willebrand factor |
| 10/12/2004 | CA1341458C Modified human t-pa |
| 10/11/2004 | CA2423897A1 Methods for treating lung infections and lung tumors and for treating and preventing lung metastases |
| 10/10/2004 | CA2425086A1 Method of increasing the delayed-type hypersensitivity response by infusing lfa-1 specific antibodies |
| 10/07/2004 | WO2004086048A1 Diagnosis of advanced cancer |
| 10/07/2004 | WO2004086039A2 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 10/07/2004 | WO2004085998A2 Biomimetic hierarchies using functionalized nanoparticles as building blocks |
| 10/07/2004 | WO2004085712A2 Multi-functional polymeric materials and their uses |
| 10/07/2004 | WO2004085682A2 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza |
| 10/07/2004 | WO2004085666A2 Secreted proteins |
| 10/07/2004 | WO2004085665A2 Nucleic acid ligand to b. anthracis protective antigen |
| 10/07/2004 | WO2004085664A2 Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use |
| 10/07/2004 | WO2004085659A2 Mutant vesicular stomatitis viruses and uses thereof |
| 10/07/2004 | WO2004085658A1 Mutant vesicular stomatitis viruses and use thereof |
| 10/07/2004 | WO2004085654A2 Modulation of cell phenotype by inhibitory rna |
| 10/07/2004 | WO2004085653A1 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 10/07/2004 | WO2004085648A2 Nogo receptor binding protein |
| 10/07/2004 | WO2004085647A1 Low-molecular weight peptides inhibiting ion channel activity |
| 10/07/2004 | WO2004085646A1 Cyclic amp response element activator proteins and uses related thereto |
| 10/07/2004 | WO2004085645A1 Rna interference in fish |
| 10/07/2004 | WO2004085637A1 Treatment of infection due to clostridium difficile |
| 10/07/2004 | WO2004085630A1 Perivascular mesenchymal precursor cells |
| 10/07/2004 | WO2004085621A2 Gene expression in breast cancer |
| 10/07/2004 | WO2004085617A2 Timp3 as vegf inhibitor |
| 10/07/2004 | WO2004085505A2 Long acting biologically active conjugates |
| 10/07/2004 | WO2004085500A1 Polymeric modifiers and pharmaceutical compositions |
| 10/07/2004 | WO2004085471A2 Glp-2 derivatives |
| 10/07/2004 | WO2004085469A2 Secreted protein family |
| 10/07/2004 | WO2004085461A2 Tumour-associated peptides binding to mhc molecules |
| 10/07/2004 | WO2004084950A2 Cell targeting methods and compositions |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084943A1 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation |
| 10/07/2004 | WO2004084942A2 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/07/2004 | WO2004084938A1 Improved vaccines |
| 10/07/2004 | WO2004084937A1 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses |
| 10/07/2004 | WO2004084934A1 Asthma preparation |
| 10/07/2004 | WO2004084933A1 Elevation of adenosine level by cytokine-induced expression of cd73 |
| 10/07/2004 | WO2004084932A2 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 10/07/2004 | WO2004084931A1 Use of chemokine receptor agonists for stem cell transplantation |
| 10/07/2004 | WO2004084930A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 10/07/2004 | WO2004084929A1 USE OF proNGF, IN PARTICULAR FOR HEALING WOUNDS OF THE CORNEA AND THE SKIN |
| 10/07/2004 | WO2004084928A1 S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment |
| 10/07/2004 | WO2004084927A2 Compositions for inducing of immunotolerance |
| 10/07/2004 | WO2004084921A1 Perivascular mesenchymal precursor cell induced blood vessel formation |
| 10/07/2004 | WO2004084892A1 Use of ritonavir for the treatment of unconjugated hyperbilirubinemia |
| 10/07/2004 | WO2004084859A2 Nasal calcitonin formulations containing chlorobutanol |
| 10/07/2004 | WO2004084839A2 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin |
| 10/07/2004 | WO2004084837A2 Methods and compositions for treating and preventing inflammatory conditions |
| 10/07/2004 | WO2004084835A2 Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor |
| 10/07/2004 | WO2004084828A2 Keratinocyte-fibrocyte concomitant grafting for wound healing |
| 10/07/2004 | WO2004084827A2 Reduction of zinc-induced neurotoxic injury by blockade of nitric oxide synthesis |
| 10/07/2004 | WO2004084825A2 Wound healing composition derived from low platelet concentration plasma |
| 10/07/2004 | WO2004084821A2 Hemipteran glutamate decarboxylase |
| 10/07/2004 | WO2004084820A2 Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients |
| 10/07/2004 | WO2004084812A2 Tamandarin analogs and fragments thereof and methods of making and using |
| 10/07/2004 | WO2004084811A2 Crystals and structures of epidermal growth factor receptor kinase domain |
| 10/07/2004 | WO2004084810A2 Novel imidazoline receptor homologs |
| 10/07/2004 | WO2004084800A2 A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use |
| 10/07/2004 | WO2004084711A2 Methods of detecting neurological disorders |
| 10/07/2004 | WO2004075919A3 Compounds for protein stabilization and methods for their use |